Altimmune
ALT • NASDAQ
Altimmune is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jerome Benedict Durso, with a market cap of $392.9M.
Market Cap$392.9M
Employees59.0
CEOJerome Benedict Durso
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
ALT
Altimmune FAQ
Common questions about Altimmune
Altimmune is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $1.0K.
Altimmune has approximately 59 employees.